52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

More
Oct 06, 2025
Addex Therapeutics - New Depositary Receipt Announcement

No DR Special Notices are available.

No DR Events are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
GAMMA Investing LLC 121
RhumbLine Advisers LP 72
SBI Securities Co., Ltd. 5
TOP MUTUAL FUND HOLDERS POSITION

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol ADXN
CUSIP 00654J206
DR Venue NASDAQ Stock Market
DR ISIN US00654J2069
Ratio DR:ORD 1:120
Country Switzerland
Effective Date Oct 06, 2025
Depositary BK (Sponsored)
Industry Pharma. & Biotech.
Books Open/Closed Open
Addex Therapeutics is a clinical-stage biopharmaceutical group specializing in the discovery, development, and commercialization of small-molecule drugs targeting neurological disorders. The Company focuses on allosteric modulators of G-protein coupled receptors and enzymes, with key programs including Dipraglurant (mGlu5 NAM) for Parkinson's disease levodopa-induced dyskinesia and brain injury recovery, and ADX71149 (mGlu2 PAM) for schizophrenia and anxious depression. The Company also advances preclinical assets such as GABAB PAM for pain, addiction, and cough.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.1000
Cancellation up to $0.1000
Cash Distribution up to $0.1000
Issuance up to $0.1000
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.1000
Rights - Issuance up to $0.1000
Stock Dividend up to $0.1000
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Nov.25 7.66 75,231 3,960
Oct.25 9.11 487,085 22,140
Sep.25 9.46 1,229,669 58,556

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE